Bromocriptine Mesylate Tablet
Product Images NDC 70954-978

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 70954-978). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container One (Container One)

Label for Bromocriptine Mesylate Tablets USP 2.5 mg oral tablets, containing 30 tablets per bottle. Distributed by ANI Pharmaceuticals, Inc., manufactured by Esjay Pharma Private Limited, India. Label includes storage instructions, barcode, and the marking "NVZ" on the right side.*

FDA Label Image

Container Two (Container Two)

Bromocriptine Mesylate Tablets USP 2.5 mg oral tablets packaging label, containing 100 tablets. Distributed by ANI Pharmaceuticals, Inc., manufactured by Esjay Pharma Private Limited. The label includes storage instructions, NDC 70954-978-20, and a barcode.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of Bromocriptine Mesylate depicting its molecular framework, including rings and functional groups, with its molecular formula (C32H40BrN5O5) and molecular weight (750.70) shown, along with the mesylate (CH3SO3H) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.